Sucharita Mistry, PhD

Short-term androgen deprivation therapy alone or in combination with pelvic lymph node radiotherapy can improve the efficacy of prostate bed radiotherapy.

A rectum-preserving strategy may produce outcomes similar to standard resection-based treatment for locally advanced rectal adenocarcinoma.

The incidence of esophageal cancer nearly doubled, and this was not due to an increase in screening.

Immunotherapy prolonged survival compared with platinum chemotherapy.

Combining either oleclumab or monalizumab with durvalumab provided a progression-free survival benefit over durvalumab alone.

Adding elotuzumab to lenalidomide and dexamethasone did not improve any efficacy outcomes.

Segmentectomy prolonged 5-year overall survival in a phase 3 trial.

Having a high blood tumor mutational burden was associated with a significant improvement in response and a trend toward improvement in survival outcomes.

Tislelizumab reduced the risk of death by 30%, when compared with chemotherapy.

Researchers observed a 61% reduction in the risk of invasive cancer among patients who completed a home exercise program and took vitamin D3 and omega-3 fatty acids daily.